Cumberland Pharmaceuticals Pitch Deck

Duchenne Muscular Dystrophy (DMD) ☐ ■ ☐ A rare, fatal, genetic neuromuscular disease characterized by the progressive loss of muscle which results in deterioration of the skeletal, heart and lung muscles New data demonstrates ifetroban could prevent cardiac fibrosis and improve cardiac function Cumberland is investigating ifetroban for the treatment of cardiomyopathy associated with DMD The FDA awarded just over $1 million in Orphan Drug Grant funding for this unmet medical need IND cleared and Phase II study is underway for the treatment of DMD cardiomyopathy

View entire presentation